Doctors from the Shanghai Medical Center have developed a new combination chemotherapy to combat thrice-negative breast cancer - a particularly serious form of cancer.

In the course of research, it turned out that thanks to the new method of treatment, the percentage of survivors of late-stage triple negative cancer surviving during the first five years increased.

This form of the disease is usually fatal.. But only 15–20% of patients are diagnosed with it.. Specialized treatment did not exist before - only a standard course of chemotherapy was used. In this case, the survival rate with this treatment was 80%. Earlier, new methods of therapy did not lead to an improvement in the result..

However, scientists synthesized a new drug capecitabine. It is used for chemotherapy in patients with advanced remission of breast cancer. For five years of testing, 585 patients from 35 hospitals in China took part in them..

297 of them were treated with the new combination therapy.

Thanks to capecitabine, recurrence of breast cancer decreased by 41%, and mortality during the first five years of remission - by 86.3% (compared with the same values \u200b\u200bwhen using only traditional chemotherapy).

In the near future, scientists plan to study the subtypes of this type of disease and develop a more targeted methodology for its treatment..

https: // sundaynews. info /.

Keywords:.